Maria Prins

Author PubWeight™ 153.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003 5.85
2 Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS 2006 3.23
3 The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology 2013 3.14
4 Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction 2007 3.08
5 Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis 2007 2.90
6 Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS 2009 2.50
7 GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J Infect Dis 2005 2.33
8 Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam. J Hepatol 2009 2.31
9 Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study. AIDS 2011 2.28
10 A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 2008 2.25
11 Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS 2009 2.07
12 Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis 2004 1.85
13 Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. AIDS 2010 1.81
14 Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction? Addiction 2013 1.81
15 Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol 2002 1.79
16 Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users. Drug Alcohol Depend 2005 1.69
17 Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis 2012 1.66
18 The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS 2011 1.65
19 Unravelling the impact of ethnicity on health in Europe: the HELIUS study. BMC Public Health 2013 1.59
20 Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis 2014 1.59
21 Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol 2005 1.56
22 Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users. Eur J Epidemiol 2007 1.52
23 Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. J Immunol 2002 1.52
24 Hepatitis C virus (HCV) antibody dynamics following acute HCV infection and reinfection among HIV-infected men who have sex with men. Clin Infect Dis 2014 1.50
25 Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia. Clin Infect Dis 2011 1.50
26 Long-term outcome of chronic drug use: the Amsterdam Cohort Study among Drug Users. Am J Epidemiol 2005 1.39
27 Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. Int J Epidemiol 2012 1.39
28 Survival and mortality of people infected with HIV in low and middle income countries: results from the extended ALPHA network. AIDS 2007 1.38
29 Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort. PLoS One 2011 1.38
30 The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy. AIDS 2006 1.37
31 Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women. Am J Epidemiol 2008 1.35
32 Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS 2011 1.31
33 Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behavior. Sex Transm Dis 2008 1.26
34 High prevalence of sexually transmitted infections in HIV-infected men during routine outpatient visits in the Netherlands. Sex Transm Dis 2012 1.25
35 Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles. J Clin Microbiol 2009 1.24
36 Recommendations for the management of hepatitis C virus infection among people who inject drugs. Clin Infect Dis 2013 1.23
37 Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study. J Acquir Immune Defic Syndr 2008 1.20
38 Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis 2013 1.19
39 Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study. AIDS 2006 1.18
40 Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003. J Acquir Immune Defic Syndr 2005 1.14
41 Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands. J Med Virol 2005 1.14
42 Less decrease in risk behaviour from pre-HIV to post-HIV seroconversion among MSM in the combination antiretroviral therapy era compared with the pre-combination antiretroviral therapy era. AIDS 2012 1.13
43 HIV incidence and HIV testing behavior in men who have sex with men: using three incidence sources, The Netherlands, 1984-2005. AIDS 2007 1.13
44 HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes. Blood 2011 1.13
45 Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997. Gastroenterology 2012 1.13
46 Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection. AIDS 2004 1.11
47 Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual behaviour. AIDS 2004 1.10
48 The HIV RNA setpoint theory revisited. Retrovirology 2007 1.06
49 Natural history of HIV-control since seroconversion. AIDS 2013 1.02
50 Transient lowering of the viral set point after temporary antiretroviral therapy of primary HIV type 1 infection. AIDS Res Hum Retroviruses 2010 1.02
51 Colonial history and contemporary transmission shape the genetic diversity of hepatitis C virus genotype 2 in Amsterdam. J Virol 2012 1.02
52 Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project. Eur J Gastroenterol Hepatol 2011 1.00
53 Declining trend in transmission of drug-resistant HIV-1 in Amsterdam. AIDS 2004 1.00
54 HIV and sexual risk behavior among commercial sex workers in the Netherlands. Arch Sex Behav 2008 1.00
55 Evolution of transmitted HIV-1 with drug-resistance mutations in the absence of therapy: effects on CD4+ T-cell count and HIV-1 RNA load. Antivir Ther 2006 0.99
56 Short-term CD4 cell response after highly active antiretroviral therapy initiated at different times from seroconversion in 1,500 seroconverters. J Acquir Immune Defic Syndr 2003 0.99
57 Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level. Eur J Public Health 2003 0.98
58 The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women. AIDS 2002 0.98
59 Declining AIDS mortality in Amsterdam: contributions of declining HIV incidence and effective therapy. Epidemiology 2004 0.96
60 Recreational drug use during sex and sexually transmitted infections among clients of a city sexually transmitted infections clinic in Amsterdam, the Netherlands. Sex Transm Dis 2012 0.96
61 Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection. AIDS 2015 0.96
62 HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls. AIDS 2016 0.95
63 Transitions in drug use in a new generation of problem drug users in Amsterdam: a 6-year follow-up study. Eur Addict Res 2009 0.94
64 Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration. AIDS 2011 0.94
65 Can migrants from high-endemic countries cause new HIV outbreaks among heterosexuals in low-endemic countries? AIDS 2010 0.93
66 Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution. AIDS Res Hum Retroviruses 2003 0.93
67 Low incidence of HIV-1 superinfection even after episodes of unsafe sexual behavior of homosexual men in the Amsterdam Cohort Studies on HIV Infection and AIDS. J Infect Dis 2011 0.92
68 Increasing sexual risk behaviour among Dutch men who have sex with men: mathematical models versus prospective cohort data. AIDS 2012 0.91
69 Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities. Vaccine 2010 0.91
70 Stabilizing incidence of hepatitis C virus infection among men who have sex with men in Amsterdam. J Acquir Immune Defic Syndr 2014 0.90
71 Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995-2010. AIDS 2014 0.90
72 Do HIV disease progression and HAART response vary among injecting drug users in Europe? Eur J Epidemiol 2005 0.90
73 Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam. Eur J Gastroenterol Hepatol 2012 0.90
74 HIV transmission patterns among The Netherlands, Suriname, and The Netherlands Antilles: a molecular epidemiological study. AIDS Res Hum Retroviruses 2010 0.89
75 Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development. J Acquir Immune Defic Syndr 2005 0.88
76 Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective? PLoS One 2013 0.88
77 Using mass media and the Internet as tools to diagnose hepatitis C infections in the general population. Am J Prev Med 2011 0.86
78 Hepatitis C in the general population of various ethnic origins living in the Netherlands: should non-Western migrants be screened? J Hepatol 2011 0.86
79 Absence of HIV-1 superinfection 1 year after infection between 1985 and 1997 coincides with a reduction in sexual risk behavior in the seroincident Amsterdam cohort of homosexual men. Clin Infect Dis 2010 0.86
80 Unexpectedly high proportion of drug users and men having sex with men who develop chronic hepatitis B infection. J Hepatol 2012 0.86
81 Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: a population-based study in Amsterdam. Sex Transm Dis 2010 0.86
82 Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy. AIDS 2016 0.85
83 Screening for hepatitis B and C in first-generation Egyptian migrants living in the Netherlands. Liver Int 2013 0.85
84 Low prevalence of asymptomatic sexually transmitted infections in HIV-infected heterosexuals visiting an HIV clinic in the Netherlands. AIDS 2012 0.85
85 Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour. Addiction 2006 0.85
86 Low bone mineral density, regardless of HIV status, in men who have sex with men. J Infect Dis 2012 0.85
87 People with multiple tattoos and/or piercings are not at increased risk for HBV or HCV in The Netherlands. PLoS One 2011 0.85
88 Tuberculosis risk varies with the duration of HIV infection: a prospective study of European drug users with known date of HIV seroconversion. AIDS 2003 0.85
89 Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review. BMC Public Health 2014 0.84
90 Condom use rather than serosorting explains differences in HIV incidence among men who have sex with men. J Acquir Immune Defic Syndr 2007 0.84
91 Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users. Epidemics 2012 0.84
92 Identification of a new genotype of Torque Teno Mini virus. Virol J 2013 0.84
93 What do Dutch MSM think of preexposure prophylaxis to prevent HIV-infection? A cross-sectional study. AIDS 2015 0.83
94 HIV-infected men who have sex with men who identify themselves as belonging to subcultures are at increased risk for hepatitis C infection. PLoS One 2013 0.83
95 Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985-1996. J Infect Dis 2002 0.83
96 Impact of pregnancy and menopause on CD4 cell counts. J Acquir Immune Defic Syndr 2005 0.82
97 White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment. AIDS 2016 0.82
98 No impact of hepatitis C virus infection on mortality among drug users during the first decade after seroconversion. Clin Gastroenterol Hepatol 2011 0.82
99 Modelling the impact of chlamydia screening on the transmission of HIV among men who have sex with men. BMC Infect Dis 2013 0.82
100 Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam. Int J Drug Policy 2011 0.82
101 Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine. AIDS 2016 0.82
102 Undetectable viral load and the decision to engage in unprotected anal intercourse among HIV-positive MSM. AIDS Behav 2013 0.82
103 Sexually transmitted infections screening at HIV treatment centers for MSM can be cost-effective. AIDS 2013 0.81
104 Combination antiretroviral therapy failure and HIV super-infection. AIDS 2008 0.81
105 The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam. Addiction 2012 0.81
106 Infection with concurrent multiple hepatitis C virus genotypes is associated with faster HIV disease progression. AIDS 2004 0.81
107 How patterns of migration can influence the heterosexual transmission of HIV in The Netherlands. Sex Transm Infect 2011 0.81
108 Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status. AIDS 2014 0.80
109 Reasons for compliance or noncompliance with advice to test for hepatitis C via an internet-mediated blood screening service: a qualitative study. BMC Public Health 2011 0.79
110 Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands. AIDS 2009 0.79
111 Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs. Drug Alcohol Rev 2012 0.79
112 Genetics of spontaneous clearance of hepatitis C virus infection: a complex topic with much to learn. Hepatology 2014 0.79
113 Factors associated with the initiation of cocaine and heroin among problem drug users: reflections on interventions. Subst Use Misuse 2007 0.78
114 Prognostic factors for important clinical outcomes in patients with a severe infection. Int J Emerg Med 2010 0.78
115 Cohort- and time-specific associations of CTLA4 genotypes with HIV-1 disease progression. AIDS 2006 0.78
116 Changes in HIV RNA and CD4 cell count after acute HCV infection in chronically HIV-infected individuals. J Acquir Immune Defic Syndr 2015 0.78
117 Two decades of hepatitis B infections among drug users in Amsterdam: are they still a high-risk group? J Med Virol 2009 0.78
118 Genetic characterization of multiple hepatitis C virus infections following acute infection in HIV-infected men who have sex with men. AIDS 2015 0.77
119 Do sexual risk behaviour, risk perception and testing behaviour differ across generations of migrants? Eur J Public Health 2013 0.77
120 Treatment as prevention among injecting drug users; extrapolating from the Amsterdam cohort study. AIDS 2014 0.77
121 White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy. AIDS 2016 0.77
122 Difference in Aortic Stiffness Between Treated Middle-Aged HIV Type 1-Infected and Uninfected Individuals Largely Explained by Traditional Cardiovascular Risk Factors, With an Additional Contribution of Prior Advanced Immunodeficiency. J Acquir Immune Defic Syndr 2016 0.77
123 High awareness of hepatitis C virus (HCV) but limited knowledge of HCV complications among HIV-positive and HIV-negative men who have sex with men. AIDS Care 2013 0.76
124 Common bile duct dilatation in drug users with chronic hepatitis C is associated with current methadone use. J Addict Med 2014 0.76
125 The sexual transmission rate of HCV among heterosexual couples. Hepatology 2013 0.76
126 Is Group Sex a Higher-Risk Setting for HIV and Other Sexually Transmitted Infections Compared With Dyadic Sex Among Men Who Have Sex With Men? Sex Transm Dis 2016 0.75
127 Motives of Dutch men who have sex with men for daily and intermittent HIV pre-exposure prophylaxis usage and preferences for implementation: A qualitative study. Medicine (Baltimore) 2016 0.75
128 An update on HIV related epidemiological research. Eur J Epidemiol 2004 0.75
129 Response to 'GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality' by Bjorkman et al. AIDS 2004 0.75
130 Drug users in Amsterdam: are they still at risk for HIV? PLoS One 2013 0.75
131 Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis. BMC Infect Dis 2014 0.75
132 Advancing Migrant Access to Health Services in Europe (AMASE): Protocol for a Cross-sectional Study. JMIR Res Protoc 2016 0.75
133 MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection. AIDS 2017 0.75
134 Earlier Detection of Hepatitis C Virus Infection Through Routine Hepatitis C Virus Antibody Screening of Human Immunodeficiency Virus-Positive Men Who Have Sex With Men Attending A Sexually Transmitted Infection Outpatient Clinic: A Longitudinal Study. Sex Transm Dis 2016 0.75
135 The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands. AIDS 2017 0.75
136 Ongoing risk behavior and the presence of HCV-RNA affect the hepatitis C virus (HCV)-Specific CD4(+) T cell response. Viral Immunol 2013 0.75
137 Men who have sex with men starting pre-exposure prophylaxis (PrEP) are at risk of HCV infection: evidence from the Amsterdam PrEP study. AIDS 2017 0.75
138 Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy. AIDS 2017 0.75
139 Limited overlap between phylogenetic HIV and HCV clusters illustrates the dynamic sexual network structure of Dutch HIV-infected MSM. AIDS 2017 0.75
140 Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries. AIDS 2017 0.75
141 Impact of CCR5 Delta32/+ deletion on herpes zoster among HIV-1-infected homosexual men. Eur J Epidemiol 2006 0.75
142 HIV is an important risk factor for human papillomavirus types 16 and 18 seropositivity among sexually active men who have sex with men. Sex Transm Dis 2015 0.75